Type 2 Diabetes Mellitus Clinical Trial
Official title:
Investigating the Acute Effect of Alternative Forms of Physical Activity in a Multi-ethnic Population: The Yoga Study
The amount of people with diabetes has now reached over 4 million in the United Kingdom. Type
2 Diabetes accounts for the majority of all cases of diabetes and increases the risk of many
other diseases, such as heart disease.
Research has shown that individuals from South Asian descent have elevated risk of certain
chronic diseases, such as type 2 diabetes and cardiovascular disease. The risk of developing
these diseases can be reduced by engaging in a healthy lifestyle. One component of a healthy
lifestyle is engaging in physical activity. However, previous research has shown that South
Asian individuals engage in less physical activity, compared to other ethnicities. It is not
yet wholly understood why South Asians engage in less physical activity, but it is vitally
important to try and find new ways to increase South Asian physical activity levels.
Therefore, the investigators have worked with South Asian communities in identifying
culturally appropriate forms of physical activity. From this, yoga and walking were
identified as two forms of culturally appropriate physical activity. This study will test and
compare whether yoga and light intensity walking can be effectively used in the prevention of
type 2 diabetes. The results of this study will help the investigators and health policy
makers understand how South Asians and other ethnicities respond to exercise, the therapeutic
benefits of yoga and help inform future diabetes prevention programmes within multi-ethnic
communities.
Physical activity, commonly defined as any movement of skeletal muscle that requires low-mid
level energy expenditure has long been associated with improving cardiometabolic health.
Furthermore, increased PA has more recently been associated with decreased all-cause and
chronic disease mortality. Evidence on lifestyle risk factors such as PA continues to grow
and demonstrate associations with improved health. Interestingly, evidence has suggested type
2 diabetes is a 'lifestyle disease', with 80-90% of the prevalence in any given ethnic group
explained by lifestyle and environmental factors. This suggests lifestyle factors, such as PA
and diet may play a pivotal role in the prevention and management of T2D. The number of
individuals with diabetes has risen from 108 million in 1980 to 425 million in 2017, with
global prevalence in over 18 year olds rising from 4.7% to 8.5% in the same time period. This
illustrates the importance of PA in preventing and managing T2D.
Diabetes is a disease characterised by chronic hyperglycaemia with disturbances to
carbohydrate metabolism, resulting from the body's impaired ability to produce or respond to
insulin. Diabetes can lead to a number of complications which can reduce a person's quality
of life and life expectancy. The main cause of premature mortality with diabetes is
cardiovascular disease. Insulin resistance is suggested to be the predominant factor in the
aetiology of T2D. PA has been shown to be a stimulator of insulin sensitivity, both acutely
and chronically. Epidemiological data on PA (and other lifestyle habits) and T2D is important
as it provides associations between exposures and the disease. This research can give a sense
of an association and where robust evidence reinforces these associations, it can be the
starting point for initiating disease prevention programmes based on reducing/increasing
exposure to the risk/preventative factor.
A systematic review and network meta-analysis of lifestyle, pharmacological and surgical
interventions stated that lifestyle interventions, which included exercise, are beneficial in
reducing the risk of developing T2D, compared to standard care. When focusing on lifestyle
interventions, diet plus exercise plus pedometer had the highest probability of being
effective (HR 0.35 95% CI [0.11-1.14]). Exercise had the second highest probability of being
the most effective lifestyle intervention (HR 0.51 95% CI [0.33-0.82]). The Indian Diabetes
Prevention Programme found improved lifestyle significantly improved cardiometabolic health
in a 42-month study. Improved lifestyle accounted for educational sessions revolving around
improving diet and then engaging in PA. When comparing control, metformin, lifestyle and
lifestyle + metformin groups it was found metformin, lifestyle and lifestyle & metformin
groups significantly delayed time to diabetes, compared to control. The two groups that
involved positive lifestyle changes delayed time to diabetes marginally longer than the
metformin group. The solely lifestyle group delayed time to diabetes the longest over the
entire 42-month period. Similarly, The Diabetes Prevention Program found that incorporating
positive lifestyle changes significantly reduced the cumulative incidence of T2D, compared to
metformin and placebo groups. The lifestyle group were instructed to engage in 150min.week-1
of PA. There was a 58% reduction in incidence of T2D in the lifestyle group, compared to
placebo, in a 4-year follow-up. When participants were split into their respective
ethnicities, American Indians and Asians saw the greatest reductions in T2D incidence. At 10
year post trial follow up, the lifestyle group still had significantly lower cumulative
incidence of T2D.
The molecular mechanisms by which PA affects insulin have been heavily researched. In brief,
after one bout of exercise there is an immediate increase in glucose uptake to the skeletal
muscle, which is in response to muscle contraction. This increase is thought to be due to
increased GLUT-4 translocation to the cell surface, which increases insulin sensitivity.
Additionally, exercise may increase oxidative metabolism in mitochondria in the skeletal
muscle. An increase in the size and number of mitochondria in the cells improves oxidative
capacity, decreasing the amounts of TG and fatty acids. TG and fatty acids interfere with the
insulin signalling process, which may cause insulin resistance. This reiterates the
importance of PA in T2D prevention and management. Additionally, physical inactivity and
sedentary behaviour have both been noted to disrupt normal metabolic state and chronically
increase insulin resistance/decrease insulin sensitivity.
Other mechanisms that PA may improve T2D by are improving lipoprotein profile, endothelial
function (and subsequently hypertension), reducing obesity and increasing anti-inflammatory
effects.
Evidently, PA is vitally important in the prevention and management of T2D. However, rates of
PA are worryingly low in the UK and globally. Globally, it is stated 1 in 4 adults are not
active enough and more than 80% of world's adolescent population are insufficiently
physically active (WHO). Within the UK, 39% (20 million) of adults do not meet recommended
guidelines for PA. Importantly, PA levels in UK South Asian populations are reported to be
lower, compared to White European populations. This trend is particularly evident among women
and older individuals. Consequently, specific ethnicities may need culturally appropriate and
alternative forms of PA to engage them. To date, public health guidelines have largely been
based on results from studies in Caucasian populations. It is essential that governments and
public health organisations engage individuals in more novel, appropriate and culturally
specific practices.
Therefore, researching culturally appropriate and alternative forms of exercise is important
in understanding whether different types of exercise will engage individuals more and improve
adherence, ultimately improving health. For example, SAs form the largest ethnic minority
group in the UK and 1 in 5 individuals globally and while it is known PA can positively
impact the health of SAs, it is not fully understood what types of PA can engage SA ethnic
groups most effectively. This is of particular importance because the prevalence of T2D is 2
to 4 times higher in SAs, compared to WEs. India is estimated to have a diabetes prevalence
of 134.3 million by 2045, with Pakistan and Bangladesh estimated at 16.1 and 13.7 million,
respectively.
Accordingly, culturally appropriate forms of exercise are needed. Intervention trial data has
suggested that yoga may yield similar health benefits to conventional exercise. Yoga is an
ancient Indian tradition that embodies unity of body, mind, emotion and energy and has been
part of traditional Indian spiritual practice for millennia. There are different forms of
yoga that focus on slightly different aspects of one's self, with these respective
philosophies varying focus on meditation (dhyana), body postures (asana) and breathing
techniques (pranayama). Regardless of these different philosophies, yoga has over recent
years become more prominent in improving physical and mental wellbeing worldwide.
Two recent systematic reviews on yoga and T2D state yoga improves HbA1c, fasting blood
glucose and postprandial blood glucose. Additionally, significant improvements were found in
lipid profile, blood pressure and body composition. Overall, the metabolic benefits of yoga
are not fully understood, particularly in those at high-risk of T2D. Further research is
required on the metabolic benefits of yoga. Additionally, it is suggested that yoga may also
have benefits to mental health, quality of life and emotional state. Data are needed to
evaluate how individuals may respond psychologically to yoga, compared to traditional
exercise, especially when used as a therapy to improve metabolic health in those at high
diabetes and cardiovascular risk.
There is a gap in the literature investigating the metabolic benefits of culturally
appropriate and alternative forms of exercise in different ethnicities. Specifically, there
is a lack of high-quality research investigating the health benefits of yoga in relation to
T2D prevention, and comparing health benefits of yoga and traditional forms of PA. Therefore,
this research will investigate the effects of yoga on glycaemic control in a multi-ethnic
population at risk of type 2 diabetes and to compare these effects against matched
traditional exercise and a non-exercise control.
Statistical design Based on a previous study undertaken by the investigators group in a
multi-ethnic population (https://clinicaltrials.gov/ct2/show/NCT02453204), 24 are needed to
complete the trial. This is based on estimating a reduction in incremental area under the
insulin curve from 76 to 53 mU/l x hr (30% reduction) in either exercise intervention group,
a standard deviation of 38 mU/l x hr, a within person correlation of 0.05, a power of 80% and
a significance of 0.05.
Study Setting The study will be co-ordinated within the Leicester Biomedical Research Centre
(Leicester Diabetes Centre) at the Leicester General Hospital. Clinical measurement sessions
will be carried out by the appointed research team. Participants will be asked to visit the
study centre on six occasions.
Study design This study is a three period crossover design. There are three experimental
conditions (yoga, continuous exercise and control) and participants will be randomised to one
of six sequences requiring them to complete all three conditions.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |